Skip to main content
Log in

The antibacterial activity in vitro and β-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides

Antibakterielle In vitro-Aktivität und β-Laktamasefestigkeit des neuen Cephalosporins HR 810; Vergleich mit fünf anderen Cephalosporinen und zwei Aminoglykosiden

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

The antibacterial activity of the cephalosporin antibiotic HR 810 was evaluated in comparison with cefoperazone, cefotaxime, ceftazidime, ceftriaxone, latamoxef, gentamicin and amikacin against 1500 clinical isolates. HR 810 is the antibiotic with the broadest antimicrobial spectrum. It is also highly active against isolates of the generaPseudomonas, Enterobacter, Staphylococcus and enterococci. HR 810 is very stable against hydrolysis by plasmid-coded and chromosomally coded β-lactamases.

Zusammenfassung

Die antibakterielle Aktivität des Cephalosporinantibiotikums HR 810 wurde im Vergleich mit Cefoperazon, Cefotaxim, Ceftazidim, Ceftriaxon, Latamoxef, Gentamicin und Amikacin bei 1500 klinischen Isolaten untersucht. HR 810 erwies sich dabei als das Antibiotikum mit dem breitesten antimikrobiellen Spektrum, das auch Isolate der GeneraPseudomonas, Enterobacter, Staphylococcus und Enterokokken bei niedrigen Konzentrationen im Wachstum hemmt. Das Präparat ist sehr stabil gegen die Hydrolyse durch Plasmid- codierte und chromosomal codierte β-Laktamasen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Seibert, G., Klesel, N., Limbert, M., Schrinner, E., Seeger, K., Winkler, I., Lattrell, R., Blumbach, J., Dürckheimer, W., Fleischmann, K., Kirrstetter, R., Mencke, B., Ross, B. C., Scheunemann, K.-H., Schwab, W., Wieduwilt, M. HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum. Arzneimittelforsch./Drug. Res. 33 (1983) 1084–1086.

    CAS  Google Scholar 

  2. Ross, G. W., O'Callaghan, C. H. β-lactamase assays: In:Hash, J. H. (ed.): Methods in enzymology. Vol. XLIII. Antibiotics. Academic Press, New York, San Francisco, London 1975, pp. 69–85.

    Google Scholar 

  3. Neu, H. C. Thein vitro activity, human pharmacology and clinical effectiveness of new β-lactam antibiotics. Ann. Rev. Pharmacol. 22 (1982) 599–642.

    Article  CAS  Google Scholar 

  4. Eykmans, L., Beert, J. Sensitivity of gram-negative bacteria to six aminoglycoside antibiotics. Infection 5 (1977) 9–12.

    Article  Google Scholar 

  5. Muytjens, H. L., van der Ros-van de Repe, J. Comparative activities of 13 β-lactam antibiotics. Antimicrob. Agents Chemother. 21 (1982) 925–935.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Winkler, I., Klesel, N., Limbert, M., Schrinner, E., Seeger, K., Seibert, G., Blumbach, J., Wieduwilt, M.: HR 810, a new parenteral cephalosporin. VI. Behaviour towards β-lactamases and binding to penicillin binding proteins. Proceedings of the 13th International Congress of Chemotherapy, part 99 (1983) pp. 21–23.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seibert, G., Limbert, M., Winkler, I. et al. The antibacterial activity in vitro and β-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides. Infection 11, 275–279 (1983). https://doi.org/10.1007/BF01641262

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01641262

Keywords

Navigation